Back to top
more

Danimer Scientific (DNMR)

(Delayed Data from NYSE)

$0.80 USD

0.80
433,528

-0.01 (-0.79%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $0.80 0.00 (-0.61%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (147 out of 252)

Industry: Industrial Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for DNMR

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Danimer Scientific, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 59 63 286 378 6
Receivables 16 20 21 7 5
Notes Receivable 0 0 0 0 0
Inventories 25 33 25 14 7
Other Current Assets 8 10 8 5 1
Total Current Assets 108 125 340 402 19
Net Property & Equipment 445 454 316 107 72
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 31 31 13 13 28
Deferred Charges 0 0 0 0 0
Intangibles 78 81 147 2 2
Deposits & Other Assets 17 2 2 2 3
Total Assets 698 712 839 546 145
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 5 15 21 11 8
Current Portion Long-Term Debt 1 2 0 25 9
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5 5 19 9 10
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 0 0 2 5
Total Current Liabilities 16 25 43 50 34
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 1 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 381 286 261 31 74
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 1 10 1 3
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 420 335 338 107 128
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 732 676 619 501 67
Retained Earnings -454 -299 -119 -63 -50
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 278 378 500 439 17
Total Liabilities & Shareholder's Equity 698 712 839 546 145
Total Common Equity 278 378 500 439 17
Shares Outstanding 102.80 101.80 100.60 84.50 NA
Book Value Per Share 2.70 3.71 4.97 5.19 0.00

Fiscal Year End for Danimer Scientific, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 59 77 91 120
Receivables NA 16 13 14 18
Notes Receivable NA 0 0 0 0
Inventories NA 25 27 30 32
Other Current Assets NA 8 10 10 10
Total Current Assets NA 108 127 145 178
Net Property & Equipment NA 445 450 454 455
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 31 31 31 31
Deferred Charges NA 0 0 0 0
Intangibles NA 78 79 79 80
Deposits & Other Assets NA 17 15 15 14
Total Assets NA 698 721 744 779
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 5 4 4 6
Current Portion Long-Term Debt NA 1 1 2 7
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 5 6 5 7
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 0 1 1
Total Current Liabilities NA 16 15 15 25
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 381 379 376 373
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1 1 3
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 420 417 414 423
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 732 719 705 691
Retained Earnings NA -454 -415 -375 -335
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 278 304 330 356
Total Liabilities & Shareholder's Equity NA 698 721 744 779
Total Common Equity 0 278 304 330 356
Shares Outstanding 114.20 102.80 102.00 101.90 101.90
Book Value Per Share 0.00 2.70 2.98 3.24 3.49